This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

16 Dec 2011

Enlight Teams up with AZ and Novo

Enlight Biosciences has formed new partnerships with UK-based AstraZeneca and Denmark-based Novo Nordisk for the development of potentially transformational technologies.

Boston research consortium Enlight Biosciences announced yesterday that it has formed new partnerships with AstraZeneca and Novo Nordisk. Enlight, AZ and Novo will collaborate and invest in the development of potentially transformational technologies with application to their therapeutic programs. 


"This partnership reflects AstraZeneca's commitment to accessing and fostering innovation that exists outside of our own labs," said Menelas Pangalos, executive vice president, Innovative Medicines, AZ. "Enlight provides a unique opportunity for AstraZeneca and MedImmune, our biologics arm, to collaborate with our peers and contribute to the development of tools that will fundamentally enhance R&D across the industry."


"At Novo Nordisk,

Related News